Literature DB >> 8569381

Neuropsychiatric reactions with mefloquine chemoprophylaxis.

A M Croft, M J World.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8569381     DOI： 10.1016/s0140-6736(96)90500-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Bipolar disorder after mefloquine treatment.

Authors:  C Even; S Friedman; K Lanouar
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Adverse events associated with mefloquine. Risk-benefit ratio must be taken into account.

Authors:  S Dollow
Journal:  BMJ       Date:  1996-12-14

3.  Mefloquine in the nucleus accumbens promotes social avoidance and anxiety-like behavior in mice.

Authors:  Mitra Heshmati; Sam A Golden; Madeline L Pfau; Daniel J Christoffel; Elena L Seeley; Michael E Cahill; Lena A Khibnik; Scott J Russo
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

4.  Malaria Disease and Chemoprophylaxis Usage among Israeli Travelers to Endemic Countries.

Authors:  Reut Harel; Bibiana Chazan; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

5.  Investigation of the in vitro gender-specific partitioning of mefloquine in malarial infected red blood cells and plasma.

Authors:  Nongluk Seethorn; Walther H Wernsdorfer; Harald Noedl; Juntra Karbwang; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2013-09-03       Impact factor: 2.345

6.  Anti-malaria drug mefloquine induces motor learning deficits in humans.

Authors:  Thomas A van Essen; Ruben S van der Giessen; Sebastiaan K E Koekkoek; Frans Vanderwerf; Chris I De Zeeuw; Perry J J van Genderen; David Overbosch; Marcel T G de Jeu
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

7.  The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.

Authors:  Christoph R Meier; Karen Wilcock; Susan S Jick
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

8.  Reversible binocular visual loss in temporal association with artesunate-amodiaquine treatment in a child on mefloquine chemoprophylaxis.

Authors:  G O Adjei; V M Adabayeri; S H Annobil
Journal:  Ghana Med J       Date:  2012-09

Review 9.  WITHDRAWN: Mefloquine for preventing malaria in non-immune adult travellers.

Authors:  A M J Croft; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Severe neuropsychiatric reaction in a deployed military member after prophylactic mefloquine.

Authors:  Alan L Peterson; Robert A Seegmiller; Libby S Schindler
Journal:  Case Rep Psychiatry       Date:  2011-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.